11/29/2021 6:24:08 AM
Fennec Pharma Expects To Receive CRL From FDA For PEDMARK NDA
11/10/2021 6:05:25 AM
Fennec Pharma Q3 Loss Per Share $0.16 Vs Loss $0.24 Last Year
8/10/2021 6:12:12 AM
Fennec Pharma Q2 Net Loss $4.0 Mln Or $0.15/Shr Vs Loss $4.8 Mln Or $0.21/Shr Last Year
6/24/2021 6:12:33 AM
Fennec Pharma Amends Existing Senior Debt Facility With Life Sciences At Bridge Bank Increasing The Size To $20 Mln
6/22/2021 6:31:52 AM
Fennec Pharma: FDA Accepts Filing The Resubmission Of NDA For PEDMARK
5/10/2019 8:39:36 AM
Wedbush Is Cutting Fennec Pharmaceuticals Inc (FENC) FY19 Estimate To -0.61 From 2.74
5/10/2019 8:39:20 AM
Wedbush Is Cutting Fennec Pharmaceuticals Inc (FENC) Q4 19 Estimate To -0.17 From 3.37
5/10/2019 8:39:07 AM
Wedbush Is Increasing Fennec Pharmaceuticals Inc (FENC) Q3 19 Estimate To -0.16 From -0.23
5/10/2019 8:38:53 AM
Wedbush Is Raising Fennec Pharmaceuticals Inc (FENC) Q2 19 Estimate To -0.15 From -0.21
5/10/2019 8:38:18 AM
Wedbush Reiterates Fennec Pharmaceuticals Inc (FENC) At Outperform With $16 Price Target
3/14/2019 7:44:51 AM
Wedbush Reiterates Fennec Pharmaceuticals Inc (FENC) At Outperform With $16 Price Target
8/14/2018 6:54:25 AM
Wedbush Is Cutting Fennec Pharmaceuticals Inc (FENC) FY18 Estimate To -0.54 From -0.42
8/14/2018 6:54:12 AM
Wedbush Is Cutting Fennec Pharmaceuticals Inc (FENC) Q4 18 Estimate To -0.16 From -0.12
8/14/2018 6:54:00 AM
Wedbush Is Cutting Fennec Pharmaceuticals Inc (FENC) Q3 18 Estimate To -0.15 From -0.11
5/14/2018 3:59:50 PM
Wedbush Is Raising Fennec Pharmaceuticals Inc (FENC) FY18 Estimate To -0.42 From -0.62
5/14/2018 3:59:39 PM
Wedbush Is Increasing Fennec Pharmaceuticals Inc (FENC) Q4 18 Estimate To -0.12 From -0.17
5/14/2018 3:59:24 PM
Wedbush Is Increasing Fennec Pharmaceuticals Inc (FENC) Q3 18 Estimate To -0.11 From -0.16